AstraZeneca is prioritizing the US for its RSV drug due to a surge in cases. RSV, the leading cause of hospitalization for babies under a year old, is being exacerbated by a nationwide shortage of the drug. The CDC has issued guidelines on prioritizing individuals for the limited drug supply. Additionally, shortages of other medications, such as those for ADHD, cancer, and diabetes, have been disrupting hospitals and pharmacies. In response to the shortage, the CDC has released 77,000 additional doses of the RSV shot for infants. Sanofi and AstraZeneca are expediting the release of more doses of the RSV drug to address the shortage.
CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage https://t.co/KGhrOgXqvI
CDC releases 77,000 additional doses of RSV shot for infants amid shortage https://t.co/BHqMTzJAgj
CDC releases 77,000 additional doses of RSV shot for infants amid shortage https://t.co/jgNMVT4hVQ
RSV is the leading cause of hospitalization for babies under a year old. A nationwide shortage of a new drug that helps protect the youngest of infants against the infection has led the CDC to issue guidelines saying who should be prioritized. https://t.co/UlYOsE9Tkr
Shortages of over-the-counter drugs and prescription medications for ADHD, cancer and diabetes have been disrupting hospitals and pharmacies for the past year. Now, RSV treatments for infants are the latest to be affected. https://t.co/jB2iR1jkET
RSV is the leading cause of hospitalization for babies under a year old. A nationwide shortage of a new drug that helps protect the youngest of infants against the infection has led the CDC to issue guidelines saying who should be prioritized. https://t.co/UlYOsE9Tkr
Shortages of over-the-counter drugs and prescription medications for ADHD, cancer and diabetes have been disrupting hospitals and pharmacies for the past year. Now, RSV treatments for infants are the latest to be affected. https://t.co/jB2iR1jkET
RSV is the leading cause of hospitalization for babies under a year old. A nationwide shortage of a new drug that helps protect the youngest of infants against the infection has led the CDC to issue guidelines saying who should be prioritized. https://t.co/UlYOsE9Tkr
RSV is an illness that is dangerous for babies. Now, it is being made worse by a shortage of drugs to treat it. @IAmAmnaNawaz gets insight from @celinegounder. https://t.co/WwPixbli2O
AstraZeneca prioritizes US for RSV drug amid surge in cases https://t.co/2KxUhShyqN https://t.co/mxvzb9oZ2C